Eterobarb

Drug Profile

Eterobarb

Alternative Names: DMMP; Zipnotic

Latest Information Update: 08 Sep 2005

Price : $50

At a glance

  • Originator Colgate-Palmolive
  • Developer Chiesi; Colgate-Palmolive; MacroChem; Medicia
  • Class Antiepileptic drugs; Barbiturates; Neuroprotectants; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 01 Sep 2005 Discontinued - Preregistration for Epilepsy in United Kingdom (PO)
  • 01 Sep 2005 Discontinued - Preregistration for Epilepsy in Switzerland (PO)
  • 01 Sep 2005 Discontinued - Preregistration for Epilepsy in Canada (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top